ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.480
-0.185 (-11.11%)
Jul 11, 2025, 1:50 PM - Market open

ImmunoPrecise Antibodies Market Cap

ImmunoPrecise Antibodies has a market cap or net worth of $67.73 million as of July 11, 2025. Its market cap has increased by 159.51% in one year.

Market Cap
67.73M
Enterprise Value
76.21M
1-Year Change
159.51%
Ranking
Category
Stock Price
$1.48

Market Cap Chart

Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $67.73M, a decrease of -72.97%. That is a compound annual growth rate of -25.10%.

History

DateMarket Cap% Change
Jul 10, 2025 54.70M 388.39%
Dec 31, 2024 11.20M -73.83%
Dec 29, 2023 42.80M -67.05%
Dec 30, 2022 129.90M 25.14%
Dec 31, 2021 103.80M -58.58%
Dec 31, 2020 250.60M -
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 701.36B
Johnson & Johnson 373.78B
AbbVie 336.57B
Novo Nordisk 308.12B
UnitedHealth Group 277.16B
Novartis AG 240.05B
Abbott Laboratories 232.39B
AstraZeneca 216.19B
Market Cap Rankings